Physician profile
Zoe Michelle Walker
NPI 1184987406
$2,745.75
in general payments reported to CMS, 2019-2025
23 companies · $394 in 2025
The $394 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $249 · 2020: $42.37 · 2021: $251 · 2022: $523 · 2023: $626 · 2024: $661 · 2025: $394.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,681.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,681.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $815.62 | 2021-2025 | Qulipta, Ubrelvy, Vraylar |
| Novo Nordisk INC | $442.64 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Pfizer INC. | $416.77 | 2019-2025 | |
| Lilly USA, LLC | $210.81 | 2021-2025 | Mounjaro, Zepbound, Trulicity |
| Sanofi-Aventis U.S. LLC | $151.62 | 2021-2023 | |
| Glaxosmithkline, LLC. | $128.68 | 2019-2025 | Trelegy Ellipta, Arexvy |
| Astrazeneca Pharmaceuticals LP | $99.73 | 2022-2025 | Farxiga, Breztri |
| Merck Sharp & Dohme LLC | $70.50 | 2020-2025 | Vaxneuvance, Gardasil 9, Gardasil |
| Novartis Pharmaceuticals Corporation | $69.99 | 2019-2022 | |
| Intuitive Surgical, INC. | $50.00 | 2023 | Da Vinci Surgical System |
| Astellas Pharma US INC | $38.36 | 2019 | |
| Amgen INC. | $32.49 | 2019-2024 | Otezla, Repatha |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $31.16 | 2022-2023 | |
| Janssen Pharmaceuticals, INC | $30.81 | 2020 | |
| Dexcom, INC. | $30.08 | 2024 | Dexcom G6 Transmitter |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acadia Pharmaceuticals INC | $23.20 | 2022 | |
| Esperion Therapeutics, INC. | $19.77 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $15.03 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.00 | 2022 | |
| Exact Sciences Corporation | $14.92 | 2025 | Cologuard Collection Kit |
| Biohaven Pharmaceutical Holding Company LTD. | $13.94 | 2022 | |
| Xeris Pharmaceuticals, INC. | $13.63 | 2025 | Keveyis |
| Circassia INC. | $11.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zoe Walker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.